Cancer Vaccine Wins and Biotech Moves
Kilder
- Endpoints: Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccine
- STAT: STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
- STAT: STAT+: Experts scrutinize Huidagene’s disclosures after patient death
- STAT: STAT+: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions
- Endpoints: Bristol Myers' partner Biokin says bispecific ADC clears fourth cancer trial in China
- Londoninsider: Biokin's Iza-Bren Bispecific ADC Clears Lung Cancer Phase 3 Hurdle, Strengthening BMS (BMY) Global Trial Outlook - londoninsider.co.uk
- GEN: Cell Therapy Company Aims to Pioneer Analytics Automation
- GEN: CAR T Manufacturing Innovation Expands Patient Access - Genetic Engineering and Biotechnology News
- GEN: Cutting Costs in Serum-Free FGF2 Processing With Recycled Media - Genetic Engineering and Biotechnology News
- Endpoints: Amgen cans its TScan partnership; Amylyx reveals $350M offering
- wikimedia: Photo by Office of Biological and Environmental Research of the U.S. Department of Energy Office of Science, the Biological and Environmental Research Information System, Oak Ridge National Laboratory. / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.